• Archives of Pharmacal Research
• /
• 제23권2호
• /
• pp.121-127
• /
• 2000

Cannabigerol (1, CBG), methyl 4-[(2E)-3,7-dimethyl-2,6-octad ienyl)oxy]-3-methoxybenzoate (2, DTM), 5-fluorouracil (3, FU) as a reference, and cannabidiol (4, CBD) were tested for their growth inhibitory effects against KB(ATCC NO, OCL 17) cell lines using two different assays, the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazoliumbromide (MTT) assay and the sulforhod-amine B protein (SRB) assay. These compounds showed inhibitory activity in vitro in the micromolar range against KB cell lines. In general, the antitumor activities of these compounds (1, 2, 3 and 4) were dose-dependent over the micromolar concentration range of 1 to 100 M. The comparison of $IC_{50}$ values of these compounds in tumor cell lines showed that their susceptibility to these compounds decreases in the following order: DTM > CBD > 5-FU > CBG by MTT assay and DTM = CBD > 5-FU > CBG by SRB assay. CBG 1, DTM 2, 5-FU 3, and CBD 4 were tested for their cytotoxic effects on NIH 3T3 fibroblasts using two different assays, the MTT assay and SRB assay. These compounds exhibited potent cytotoxic activities in vitro in the micromolar range against NIH 3T3 fibroblasts. In general, the cytotoxic acivities of these compounds (1, 2, 3 and 4) were dose-dependent over the micromolar concentraion range of 1 to 100 M. The comparison of $CD_{50}$ values of these compounds in NIH 3T3 fibroblasts shows that their susceptibility to these compounds in decreases the following order(:) CBD > 5-FU > DTM > CBG by MTT assay, CBD > 5-FU > CBG > DTM by SRB assay. These results suggest that DTM 2 has the most growth-inhibitory activity against KB cell lines.

• 대한두경부종양학회지
• /
• 제15권2호
• /
• pp.149-155
• /
• 1999

Objectives: To study the clinical features of the primary nasal/nasopharyngeal non-Hodgkin's lymphomas and to evaluate the implication of immunophenotyping as a prognostic factor. Patients and Methods: From January 1990 to December 1997,41 patients(median age, 41 years) of primary nasal/nasopharyngeal non-Hodgkin's lymphoma were studied. The clinical records and paraffin-embedded tissue blocks were reviewed retrospectively. The histologic features, immunophenotypic findings(pan-T, pan-B, CD3, CD56) and Epstein-Barr virus in situ hybridizatios were examined. The prognostic factors for clinical outcome were evaluated in these patients. According to Ann-Arbor system, there were 30 patiets(73%) with stage IE, 4(10%) with stage IIE, 3(7%) with stage IIIE, 4(10%) with stage IVE lymphoma. Among the patients with stage IE/IIE, 4 patients received local radiation alone, 4 received chemotherapy alone, 25 received combination chemotherapy and radiotherapy and 1 refused treatment. The patients with stage IIIE/IVE were given combination chemotherapy and radiotherapy. Results: Immunophenotyping were performed in 40 patients and staining results were as follows: 3(7%) patients with B cell, 17(42%) with T cell, 18(44%) with NK/T cell(CD56 positive), and two patients with unclassifiable result. Epstein-Barr(EB) virus in situ hybridization were performed in 28 patients and 23(82%) patients had positive EBV-encoded RNAs(EBERs). 21(55%) patients achieved a complete remission. There was no difference in complete remission between radiation alone and combination therapy. With median follow-up of 30 months, 5-years disease free survival of complete responders was 60% and 5-years overall survival rate was 36%. Multivariate analysis showed that better overall survival was related with absence of B symptoms, ECOG performance${\leq}1$ and non-NK cells. Conclusion: Most of all cases were positive for EBER. Since NK/T phenotype carried the worst prognosis, analysis for CD56 expression should be done. Further prospective studies were warranted to evaluate the role of chemotherapy in stage IE/IIE.

• 대한간호학회지
• /
• 제32권5호
• /
• pp.716-726
• /
• 2002

The purpose of this study was to explore the effects of hand reflexology on the physiological.emotional responses and immunity of the patients with chronic illness. This study looked specifically at patients with chronic renal failure(CRF) and cancer patients. Method: This study was designed as a quasi-experimental nonequivalent control group pre and post test. Subjects were 54 patients who received dialysis and chemotherapy in one hospital. Thirty-one patients were assigned to the experimental group and 23 to the control group. The hand reflexology was applied to both hands of the experiment group for ten minutes each time, 5 times during three days. For data collection, physiological lab levels, immune cells of blood and questionnaires for emotional responses were measured before and after the program. Result: BT of the experiment group was decreased significantly on both of the 1st and the 5th application. PR & BP were decreased significantly on the 1st times, but not 5th times. Hb levels of the experimental group were significantly increased. And emotional responses, vigor and mood scores of the experiment group were significantly increased. B cell & CD19 were increased significantly on the experiment group. Suppressor T cell and NK cell showed significant decrease after the program, but no significant differences between the groups. Conclusion: We have found that the hand reflexology helps the chronic patients to improve physiological.emotional responses and the immune reaction. Through this result, the hand reflexology is effective as a intervention of psychoneuroimmunologic function.

• 한국식품저장유통학회지
• /
• 제23권5호
• /
• pp.718-726
• /
• 2016

단호박 분말을 이용하여 식물성 젖산균의 발효 최적화를 통한 점질물 dextran, 만니톨을 생산함으로서 물성과 맛이 개선된 푸딩형태의 단호박 젖산 발효물을 제조하였다. 단호박 농도에 따라서 젖산 발효물에 영향을 주었으며, 단호박 분말 15% 조건이 가장 양호한 물리화학적 특성을 보였다. $25^{\circ}C$에서 3일 동안 발효를 수행하였을 때 15% 단호박 분말의 젖산 발효물의 pH, 산도는 각각 3.85, 1.30%이었으며, 생균수는 $4.64{\times}10^9CFU/mL$로 높은 값을 나타내었다. 단호박 분말 paste의 발효 초기에 L값 25.02, a값 4.66, b값 13.35를 나타내었으며, 발효가 진행되면서 L값을 제외하고 감소하는 경향을 보였다. 10%, 15% 단호박 분말의 발효물은 발효 1일에 설탕의 소진율 100%를 보였으며, 발효 3일에 불용성 dextran을 각각 5.6%, 8.9%를 보였으며, 수용성 dextran은 4.5% 수준으로 유사하였다. 15% 단호박 분말의 3일 후에 발효물에 과당과 만니톨 함량은 각각 1.76%, 3.11%를 나타내었다. 15% 단호박 젖산 발효물의 점조도는 초기 $48.6Pa{\cdot}s^n$로서 가장 높은 값을 보였으며, 발효 1일 $75.1Pa{\cdot}s^n$에로 증가하였으며, 발효 3일에는 $188.8Pa{\cdot}s^n$으로 크게 증가하면서 푸딩 형태의 물성을 나타내었다. 단호박 젖산 발효물의 관능평가를 통해서 15% 단호박 젖산 발효물이 색, 단맛, 조직감에서 높은 점수로 평가되었다. 결론적으로 15% 단호박 분말과 20% 설탕혼합액을 이용하여 3일 동안 젖산 발효시킴으로서 설탕은 100% 전환되었으며, protiotic 생균 $4.6{\times}10^9CFU/mL$을 포함한 만니톨, 점질물 dextran의 생성을 통해서 기능성, 맛과 조직감이 강화된 푸딩형태의 단호박 젖산발효제품을 개발할 수 있었다.